Endotoxic shock and hyperpyrexia in urological practice.
D000293:Adolescent; D000328:Adult; D000368:Aged; D045930:Anabolic Agents / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D005334:Fever / Q000517:prevention & control*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D018805:Sepsis / Q000209:etiology / Q000517:prevention & control; D012772:Shock, Septic / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D014556:Urine / Q000382:microbiology; D014566:Urogenital System / Q000601:surgery*; D014570:Urologic Diseases / Q000382:microbiology / Q000601:surgery*
D045930:Anabolic Agents; D000892:Anti-Infective Agents, Urinary